secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001773751-24-000130
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q1 2024 revenue $278.2M (+46% YoY), net income $11.1M, raises FY guidance
--------------------------------------------------------------------------------

- Revenue $278.2M, up 46% YoY; net income $11.1M vs loss of $10.1M a year ago.
- Subscribers reached 1.7M, up 41% YoY, with a record 172k net additions.
- Adjusted EBITDA $32.3M, up 434% YoY from $6.1M; gross margin improved to 82%.
- FY2024 revenue guidance raised to $1.20-1.23B, Adjusted EBITDA to $120-135M, exceeding prior 2025 targets.
- Over 35% of subscribers now on personalized solutions; marketing spend leverage improving.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375124000130/0001773751-24-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375124000130/hims-20240506.htm
  HTML page:      https://secwatch.observer/filing/0001773751-24-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer